Fact CheckerSign in

NCT07645599Not yet recruiting

Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Function

Source: ClinicalTrials.gov · Last updated 12 Jun 2026

Brief summary (registry, in English)

This pilot study is testing a new ultrasound imaging method called Super-Resolution Ultrasound (SRU) to look at blood flow and tiny blood vessels in transplanted kidneys in very detailed images after kidney transplant surgery. The goal is to see whether changes in the kidney's small blood vessels can help predict how well the transplanted kidney will work early after transplant, including whether delayed graft function may occur. Investigators hope this technique can become a safe, noninvasive way to evaluate transplanted kidneys without needing as many invasive biopsies. It may also help doctors better assess donor kidneys at higher-risk of suboptimal functioning.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
8 Jun 2026
Start date
1 Jun 2026
Primary completion date
30 Jun 2028
Lead sponsor
Roderick Tan
NCT number
NCT07645599

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 1 Jun 2026 to the primary completion date, 30 Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Hypersensitivity to perfluten lipid microsphere and components including polyethylene glycol (PEG)
  • Unstable cardiopulmonary condition (acute myocardial infarction, acute coronary artery symptoms, worsening or unstable congestive heart failure, serious ventricular arrhythmias).
  • Known history of cardiac shunts
  • Patients who have known sickle cell disease or trait

Other

  • BMI \> 40
  • Inability to provide informed consent
  • Pregnant woman
  • Breastfeeding women

Who the study is looking for

  • For stage 1 of the study:
  • We will enroll patients ≥18 years of age
  • Patients who received a kidney transplant 2a. Patients requiring dialysis in the first 14 days after transplant 2b. Patients with working allografts not requiring dialysis (control group)
    • For stage 2 of the study
  • We will enroll patients at least 18 years of age or older
  • Patients who received a kidney transplant 2a. Patients who received kidney transplants from low KDPI kidneys (KDPI \< 35) 2b. Patients who received kidney transplants from high KDPI kidneys (KDPI \> 75)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Pittsburgh Medical Center
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.